Literature DB >> 26536463

Presence of antibodies but no evidence for circulation of MERS-CoV in dromedaries on the Canary Islands, 2015.

Carlos Gutiérrez1, María Teresa Tejedor-Junco, Margarita González, Erik Lattwein, Stefanie Renneker.   

Abstract

In 2012, a new betacoronavirus, Middle East respiratory syndrome coronavirus (MERS-CoV), was identified in humans. Several studies confirmed dromedary camels to be a potential reservoir and a source for human infection. Camels located on the Canary Islands were included in those studies and ca 10% of them were positive for MERS-CoV-specific antibodies. However, these findings could not be correctly interpreted because epidemiological information was not provided. Thus, further investigations were necessary to clarify these results. A total of 170 camels were investigated in this survey, of which seven (4.1%) were seropositive by ELISA. Epidemiological information revealed that all seropositive camels had been imported from Africa 20 or more years prior. We conclude that seropositive camels had contact with MERS-CoV in Africa and that there is no shedding of the virus among camels or people around the farms on the Canary Islands. However, the presence of antibodies in the camel herds should be monitored.

Entities:  

Keywords:  Canary Islands; MERS-Co; camels; seroprevalence

Mesh:

Substances:

Year:  2015        PMID: 26536463     DOI: 10.2807/1560-7917.ES.2015.20.37.30019

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  13 in total

1.  No Serologic Evidence of Middle East Respiratory Syndrome Coronavirus Infection Among Camel Farmers Exposed to Highly Seropositive Camel Herds: A Household Linked Study, Kenya, 2013.

Authors:  Peninah Munyua; Victor Max Corman; Austine Bitek; Eric Osoro; Benjamin Meyer; Marcel A Müller; Erik Lattwein; S M Thumbi; Rees Murithi; Marc-Alain Widdowson; Christian Drosten; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

2.  Fundamental evolution of all Orthocoronavirinae including three deadly lineages descendent from Chiroptera-hosted coronaviruses: SARS-CoV, MERS-CoV and SARS-CoV-2.

Authors:  Denis Jacob Machado; Rachel Scott; Sayal Guirales; Daniel A Janies
Journal:  Cladistics       Date:  2021-04-26       Impact factor: 5.254

3.  Fundamental evolution of all Orthocoronavirinae including three deadly lineages descendent from Chiroptera-hosted coronaviruses: SARS-CoV, MERS-CoV and SARS-CoV-2.

Authors:  Denis Jacob Machado; Rachel Scott; Sayal Guirales; Daniel A Janies
Journal:  Cladistics       Date:  2021-04-26       Impact factor: 4.714

4.  ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice.

Authors:  Naif Khalaf Alharbi; Eriko Padron-Regalado; Craig P Thompson; Alexandra Kupke; Daniel Wells; Megan A Sloan; Keith Grehan; Nigel Temperton; Teresa Lambe; George Warimwe; Stephan Becker; Adrian V S Hill; Sarah C Gilbert
Journal:  Vaccine       Date:  2017-06-01       Impact factor: 3.641

5.  Dromedary camels in northern Mali have high seropositivity to MERS-CoV.

Authors:  Darryl Falzarano; Badian Kamissoko; Emmie de Wit; Ousmane Maïga; Jacqueline Cronin; Kassim Samaké; Abdalah Traoré; Shauna Milne-Price; Vincent J Munster; Nafomon Sogoba; Mamadou Niang; David Safronetz; Heinz Feldmann
Journal:  One Health       Date:  2017-03-10

6.  Global status of Middle East respiratory syndrome coronavirus in dromedary camels: a systematic review.

Authors:  R S Sikkema; E A B A Farag; Mazharul Islam; Muzzamil Atta; C B E M Reusken; Mohd M Al-Hajri; M P G Koopmans
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

7.  Sero-prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) specific antibodies in dromedary camels in Tabuk, Saudi Arabia.

Authors:  Rafik Harrath; Faisel M Abu Duhier
Journal:  J Med Virol       Date:  2018-04-26       Impact factor: 2.327

Review 8.  MERS coronavirus outbreak: Implications for emerging viral infections.

Authors:  Awad Al-Omari; Ali A Rabaan; Samer Salih; Jaffar A Al-Tawfiq; Ziad A Memish
Journal:  Diagn Microbiol Infect Dis       Date:  2018-10-18       Impact factor: 2.803

Review 9.  Vaccines against Middle East respiratory syndrome coronavirus for humans and camels.

Authors:  Naif Khalaf Alharbi
Journal:  Rev Med Virol       Date:  2016-10-27       Impact factor: 6.989

Review 10.  Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir.

Authors:  Hamzah A Mohd; Jaffar A Al-Tawfiq; Ziad A Memish
Journal:  Virol J       Date:  2016-06-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.